RT Journal Article
SR Electronic
T1 High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 74
DO 10.1186/s40425-017-0279-5
VO 5
IS 1
A1 Davar, Diwakar
A1 Ding, Fei
A1 Saul, Melissa
A1 Sander, Cindy
A1 Tarhini, Ahmad A.
A1 Kirkwood, John M.
A1 Tawbi, Hussein A.
YR 2017
UL http://jitc.bmj.com/content/5/1/74.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.